Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Takeda Pharmaceutical Company Limited American Depositary Shares (each (NY:TAK)

13.63 +0.04 (+0.26%)
Streaming Delayed Price Updated: 11:05 AM EDT, Jul 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Takeda Pharmaceutical Company Limited American Depositary Shares (each

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Mu - The Newest Worry
Today London and New York fell on the huge drop in new employment levels in August. 
Via Talk Markets
Takeda's Breakthrough Blood Cancer Drug Flunks In Phase 3 Study
Takeda Pharmaceutical Co Ltd (NYSE: TAK) announced topline data from the Phase 3 PANTHER study evaluating pevonedistat in blood cancer indications. The trial did... 
Via Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV... 
Via Benzinga
Analyzing Takeda Pharmaceutical's Unusual Options Activity
Shares of Takeda Pharmaceutical (NYSE:TAK) saw some unusual ... 
Via Benzinga
Understanding Takeda Pharmaceutical's Unusual Options Activity
Takeda Pharmaceutical (NYSE:TAK) shares experienced unusual ... 
Via Benzinga
Takeda Provides Update on Phase 3 PANTHER (Pevonedistat-3001) Trial
From Takeda Pharmaceutical Company Limited
Via Business Wire
Moderna Reviews Contamination In Vaccine Lot Distributed In Japan
Moderna, Inc. (NASDAQ: MRNA) found itself in a controversy after Japan suspended the use of about 2.6 million doses of the company's COVID-19 vaccine following reports of... 
Via Benzinga
UK's NICE Rejects Johnson & Johnson's Darzalex Regime For Newly Diagnosed Myeloma
New guidance from the National Institute for Health and Care Excellence (NICE) has rejected a combination regimen based on Johnson & Johnson's (NYSE: JNJ)... 
Via Benzinga
Moderna Withdraws Additional COVID-19 Shots In Japan: What You Need To Know
After receiving reports on more contaminated vials and two deaths, Japan has suspended another million doses of Moderna Inc's (NASDAQ: MRNA) COVID-19... 
Via Benzinga
Topics Death
Suspected Metallic Particles Behind Moderna's Japan COVID-19 Jab Contamination: Reuters
Metallic particle is believed to be a contaminant found in a batch of Moderna Inc's (NASDAQ: MRNA) COVID-19 vaccines delivered to Japan, Japanese public broadcaster... 
Via Benzinga
Exelixis - Takeda's Cabometyx Scores Approval In Japan For Kidney Cancer
Exelixis Inc's (NASDAQ: EXEL) collaborating partner Takeda Pharmaceutical Co Ltd (NYSE: TAK) and Ono Pharmaceutical Co Ltd have received... 
Via Benzinga
Moderna Withdraws 1.6M COVID-19 Vaccine Doses In Japan Over Contamination Concerns
More than a million doses of Moderna Inc’s (NASDAQ: MRNA) coronavirus vaccine have been taken out of circulation in Japan after reports of contamination emerged, Nikkei Asia... 
Via Benzinga
BioLife Plasma Services Opens First All-Electric Plasma Donation Center
From Takeda Pharmaceutical Company Limited
Via Business Wire
Friday the Thirteenth
The stock week in points eastward was mixed. The USA markets face a bear correction. 
Via Talk Markets
Takeda To Lead Finch-Partnered Microbiome IBD Drug
Finch Therapeutics Group Inc (NASDAQ: FNCH) announced that Takeda Pharmaceutical Company Limited (NYSE: TAK) has elected to take the lead on the development of FIN... 
Via Benzinga
Why BioCryst Pharmaceuticals Rose 8% on Thursday
The company's first commercial drug launch keeps exceeding expectations. 
Via The Motley Fool
Topics Earnings
Final Results from the Longest Hereditary Angioedema Study of Active Treatment Duration Conducted to Date Support the Sustained Safety and Efficacy of TAKHZYRO® (lanadelumab) Injection for Long-Term Prevention of Hereditary Angioedema Attacks
From Takeda Pharmaceutical Company Limited
Via Business Wire
Know When To Hold 'Em, Know When To Fold 'Em ...
A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks. 
Via Talk Markets
Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie
From Takeda Pharmaceutical Company Limited
Via Business Wire
Takeda Delivers Solid First Quarter FY2021 Results, Positioning Company to Accelerate Topline Growth and Continued Pipeline Progress
From Takeda Pharmaceutical Company Limited
Via Business Wire
Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate
From Takeda Pharmaceutical Company Limited
Via Business Wire
Full News Day
The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier. 
Via Talk Markets
Topics Energy
Takeda's Narcolepsy Candidate Gets FDA Breakthrough Therapy Tag
The FDA has granted Breakthrough Therapy Designation to Takeda Pharmaceutical Company Limited's (NYSE: TAK) TAK-994 for excessive daytime sleepiness (EDS... 
Via Benzinga
U.S. Food and Drug Administration Grants Breakthrough Therapy Designation to Takeda’s Investigational Compound, TAK-994, an Oral Orexin Agonist in Clinical Development for Narcolepsy Type 1 (NT1)
From Takeda Pharmaceutical Company Limited
Via Business Wire
XBIO Stock: Xenetic Soars on Private Placement Announcement
XBIO stock is continuing a heck of a week. Just days after it was boosted by Takeda's expansion news, it's looking at a big private sale. 
Via InvestorPlace
Containment Plan
Today the US decided to cut China risks. 
Via Talk Markets
“Claw-Back” day
The rally was just as irrational as the selloff. 
Via Talk Markets
Takeda Data at ISTH 2021 Highlight the Benefits of Prophylaxis for Patients with Rare Bleeding Disorders
From Takeda Pharmaceutical Company Limited
Via Business Wire
Moderna Extends Rally With Expanded Japanese COVID-19 Vaccine Supply Deal
Moderna, Inc. (NASDAQ: MRNA) shares appear to be going from strength to strength, and the premarket price action Tuesday suggests a positive open for the fifth straight... 
Via Benzinga
Japan To Buy Additional 50M Doses Of Moderna COVID-19 Vaccine
Moderna Inc (NASDAQ: MRNA) has announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) and Takeda Pharmaceutical Co Ltd (NYSE: TAK) will... 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.